Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1.

Maroccia Z, Loizzo S, Travaglione S, Frank C, Fabbri A, Fiorentini C.

Biomed Pharmacother. 2018 May;101:929-937. doi: 10.1016/j.biopha.2018.02.140. Epub 2018 Mar 22. Review.

PMID:
29635902
2.

Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders.

Khoja S, Huynh N, Warnecke AMP, Asatryan L, Jakowec MW, Davies DL.

Psychopharmacology (Berl). 2018 Jun;235(6):1697-1709. doi: 10.1007/s00213-018-4869-9. Epub 2018 Mar 2. Review.

3.

Recent progress in the isolation, bioactivity, biosynthesis, and total synthesis of natural spiroketals.

Zhang FM, Zhang SY, Tu YQ.

Nat Prod Rep. 2018 Jan 25;35(1):75-104. doi: 10.1039/c7np00043j. Review.

PMID:
29354841
4.

Learn from microbial intelligence for avermectins overproduction.

Gao Q, Tan GY, Xia X, Zhang L.

Curr Opin Biotechnol. 2017 Dec;48:251-257. doi: 10.1016/j.copbio.2017.08.016. Epub 2017 Oct 17. Review.

PMID:
29049952
5.

Examining the role of macrolides and host immunity in combatting filarial parasites.

Carithers DS.

Parasit Vectors. 2017 Apr 14;10(1):182. doi: 10.1186/s13071-017-2116-6. Review.

6.

Honoring antiparasitics: The 2015 Nobel Prize in Physiology or Medicine.

Chen WJ.

Biomed J. 2016 Apr;39(2):93-7. doi: 10.1016/j.bj.2016.04.002. Epub 2016 Jun 6. Review.

7.

Eco-toxicological effects of the avermectin family with a focus on abamectin and ivermectin.

Bai SH, Ogbourne S.

Chemosphere. 2016 Jul;154:204-214. doi: 10.1016/j.chemosphere.2016.03.113. Epub 2016 Apr 6. Review.

PMID:
27058912
8.

Ivermectin: A Review in Rosacea.

Deeks ED.

Am J Clin Dermatol. 2015 Oct;16(5):447-52. doi: 10.1007/s40257-015-0150-8. Review.

PMID:
26254001
9.

Novel GABA receptor pesticide targets.

Casida JE, Durkin KA.

Pestic Biochem Physiol. 2015 Jun;121:22-30. doi: 10.1016/j.pestbp.2014.11.006. Epub 2014 Nov 18. Review.

PMID:
26047108

Supplemental Content

Loading ...
Support Center